And now, Moderna signs a strategic partnership with prestigious Institut Pasteur

04/02/2015 - 2 minutes

Moderna is the Biotech company that raised the biggest VC round ever ($450M) and which signs deals almost every week. It signed a $50M deal with Merck two weeks ago, and now signs a strategic partnership with prestigious Institut Pasteur from Paris through its new Venture Valera.

Moderna is developing a proprietary mRNA therapeutics platform. Instead of producing the drug to inject it into patients, it injects mRNA which penetrates into cells and will be expressed to produce the therapeutics locally. Moderna is frankly one of the most impressive Biotech company I have ever seen, during LaBiotech Tour Boston. Here is the entire interview:

Please accept preferences cookies to watch this video.

This January, Moderna launched its new venture Valera which focuses on infectious diseases. At the same time as the launch, it announced a $50M partnership with Merck. The director of research form Merck Roger M. Perlmutter stated in Forbes “We had the opportunity to really get in under the hood.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member